Skip to content

森先特科技

US · SXT #2027 按市值排名 上市于 1970
133.74 +0.32 +0.24%
实时 - 追踪5344个代码 - 心跳于233秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期(2026/Q3)披露持股的机构数量减少了1家。
  • 机构持股总比例下降了0.6个百分点。

机构持股

机构持股比例
100.37% -0.61pp
机构数量
433 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund84.09%
Hedge Fund11.29%
Public Company1.87%
Individual/Insider1.62%
Sovereign Wealth Fund1.17%
Government Pension Fund1.15%
Private Company0.35%
Insurance Company0.34%

主要股东 截至 2026-06-30

BlackRock 15.60% · 6.64M 股
Vanguard Portfolio Management, LLC 6.52% · 2.78M 股
Vanguard Capital Management, LLC 5.22% · 2.22M 股
Freemont Capital Pte. Ltd. 4.82% · 2.05M 股
State Street Global Advisors 4.04% · 1.72M 股
Janus Henderson Group plc 4.03% · 1.71M 股
Geode Capital Management, LLC 2.61% · 1.11M 股
Dimensional Fund Advisors 2.49% · 1.06M 股
Vaughan Nelson Investment Management, L.P. 2.37% · 1.01M 股
Congress Asset Management Company, LLP 2.19% · 930.34K 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 28次买入 · 18次卖出

姓名职务持股比例
Paul Manning Chairman, CEO, President & Member of Scientific Advisory Committee 0.66%
Stephen Rolfs Senior Vice President 0.32%
Michael Geraghty President of Color Group 0.11%
John Manning Senior Vice President 0.09%
Amy Jones VP of Human Resources & Senior Counsel 0.06%
Joseph Carleone Independent Lead Director & Member of Scientific Advisory Committee 0.06%
Deborah McKeithan-Gebhardt Independent Director & Member of Scientific Advisory Committee 0.05%
Essie Whitelaw Director & Member of Scientific Advisory Committee 0.04%
Tobin Tornehl Chief Accounting Officer 0.04%
Thierry Hoang -- 0.03%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-29 Joseph Carleone Independent Lead Director & Member of Scientific Advisory Committee Other Derivative Acquisition +279 --
2026-09-29 Mario Ferruzzi Independent Director & Member of Scientific Advisory Committee Other Derivative Acquisition +42 --
2026-08-04 Mario Ferruzzi Independent Director & Member of Scientific Advisory Committee Open Market Disposition -1,200 $129.48
2026-06-30 Chandrabhushan Singh -- Initial Statement of Beneficial 0 --
2026-06-29 Joseph Carleone Independent Lead Director & Member of Scientific Advisory Committee Other Derivative Acquisition +296 --
2026-06-29 Mario Ferruzzi Independent Director & Member of Scientific Advisory Committee Other Derivative Acquisition +44 --
2026-05-17 Thierry Hoang -- Open Market Disposition -400 $115.19
2026-05-03 Thierry Hoang -- Open Market Disposition -439 $114.15
2026-04-29 Freemont Capital Pte. Ltd. -- Open Market Disposition -2,127,566 $109.69
2026-04-29 Steve Morris President, Flavors & Extracts Group Open Market Disposition -200 $114.58
2026-04-22 Essie Whitelaw Director & Member of Scientific Advisory Committee Sale to Issuer -674 $99.23
2026-04-22 Essie Whitelaw Director & Member of Scientific Advisory Committee Other Acquisition +1,119 --
2026-04-22 Joseph Carleone Independent Lead Director & Member of Scientific Advisory Committee Other Acquisition +1,119 --
2026-04-22 Scott Morrison Independent Director & Member of Scientific Advisory Committee Sale to Issuer -674 $99.23
2026-04-22 Scott Morrison Independent Director & Member of Scientific Advisory Committee Other Acquisition +1,119 --
2026-04-22 Donald Landry Independent Director & Member of Scientific Advisory Committee Sale to Issuer -674 $99.23
2026-04-22 Donald Landry Independent Director & Member of Scientific Advisory Committee Other Acquisition +1,119 --
2026-04-22 Carol Jackson Independent Director & Member of Scientific Advisory Committee Sale to Issuer -674 $99.23
2026-04-22 Carol Jackson Independent Director & Member of Scientific Advisory Committee Other Acquisition +1,119 --
2026-04-22 Mario Ferruzzi Independent Director & Member of Scientific Advisory Committee Sale to Issuer -674 $99.23

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

森先特科技 讨论区 0 条评论

发表评论